Evaluating The Effects Of Cimetidine On The Elimination Of PD 0332334 From The Body

PHASE1TerminatedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Generalized Anxiety Disorder
Interventions
DRUG

PD 0332334

Single 300 mg dose of PD 0332334 immediate release capsules administered orally

DRUG

PD 0332334

Single 300 mg dose of PD 0332334 immediate release capsules administered orally on Day 2.

DRUG

cimetidine

600 mg q 6 hours cimetidine immediate release formulation administered orally on Days 1 through 5.

Trial Locations (1)

06511

Pfizer Investigational Site, New Haven

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00800280 - Evaluating The Effects Of Cimetidine On The Elimination Of PD 0332334 From The Body | Biotech Hunter | Biotech Hunter